MARKET

ACST

ACST

Acasti Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.7262
-0.0318
-4.20%
After Hours: 0.7296 +0.0034 +0.47% 19:57 01/26 EST
OPEN
0.7690
PREV CLOSE
0.7580
HIGH
0.7690
LOW
0.7100
VOLUME
19.33M
TURNOVER
--
52 WEEK HIGH
1.090
52 WEEK LOW
0.1710
MARKET CAP
70.36M
P/E (TTM)
-2.4078
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 21)
Benzinga · 4d ago
Thinking about buying stock in Lipocine, Acasti Pharma, FuelCell Energy, General Electric, or Infinity Pharmaceuticals?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LPCN, ACST, FCEL, GE, and INFI.
PR Newswire - PRF · 01/12 14:31
TRXC, WATT, EDIT and RIOT among midday movers
Gainers: Zomedica (ZOM) +86%.GeoVax Labs (GOVX) +67%.TransEnterix (TRXC) +65%.Sify Technologies (SIFY) +51%.Mesoblast (MESO) +45%.LM Funding America (LMFA) +36%.Aileron Therapeutics (ALRN) +32%.Energous (WATT) +31%.Acasti Pharma (ACST) +30%.Impinj (PI) +29%.Losers: Applied DNA Sciences (APDN) -20%.Bit Digital (BTBT) -19%.Turquoise
Seekingalpha · 01/11 17:41
ACST Stock Alert: 13 Things for Acasti Pharma Investors to Know as Shares Rocket Monday
Acasti Pharma (ACST) stock is on the rise Monday with heavy trading of its shares despite a lack of news concerning the company.
InvestorPlace.com · 01/11 16:19
Thinking about buying stock in Sundial Growers, Acasti Pharma, Transenterix, Jaguar Health, or Marathon Patent Group?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNDL, ACST, TRXC, JAGX, and MARA.
PR Newswire - PRF · 01/11 15:55
Thinking about buying stock in Zomedica, General Electric, Sundial Growers, Blink Charging, or Acasti Pharma?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ZOM, GE, SNDL, BLNK, and ACST.
PR Newswire - PRF · 01/08 15:55
Thinking about buying stock in BioNano Genomics, Ocugen, Acasti Pharma, Novan, or Transenterix?
, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BNGO, OCGN, ACST, NOVN, and TRXC.
PR Newswire - PRF · 01/05 15:50
Acasti (ACST) Moves to Buy: Rationale Behind the Upgrade
Zacks · 12/25/2020 17:00
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ACST. Analyze the recent business situations of Acasti Pharma through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ACST stock price target is 0.2487 with a high estimate of 0.2487 and a low estimate of 0.2487.
EPS
Institutional Holdings
Institutions: 37
Institutional Holdings: 3.37M
% Owned: 3.48%
Shares Outstanding: 96.89M
TypeInstitutionsShares
Increased
0
0
New
11
-1.17M
Decreased
7
267.80K
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-1.91%
Pharmaceuticals & Medical Research
-0.64%
Key Executives
Chairman/Independent Director
Roderick Carter
President/Chief Executive Officer/Director
Janelle D'Alvise
Chief Financial Officer
Brian Ford
Chief Operating Officer/Chief Scientific Officer
Pierre Lemieux
Other
Brian Groch
Independent Director
Jean-Marie Canan
Independent Director
Donald Olds
  • Dividends
  • Splits
  • Insider Activity
No Data
About ACST
Acasti Pharma Inc. is a biopharmaceutical company. The Company is focused on the research, development and commercialization of prescription drugs using omega-3 fatty acids derived from krill oil. It is developing a cardiovascular drug, CaPre (omega-3 phospholipid) for the treatment of hypertriglyceridemia. CaPre is a krill oil derived mixture containing polyunsaturated fatty acids (PUFAs), primarily composed of omega-3 fatty acids, principally eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). CaPre is designed to reduce triglycerides while also potentially providing beneficial effects on low-density lipoprotein (LDL) cholesterol (LDL-C) and high-density lipoprotein (HDL) cholesterol (HDL-C) in patients with severe hypertriglyceridemia.

Webull offers kinds of Acasti Pharma Inc stock information, including NASDAQ:ACST real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACST stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ACST stock methods without spending real money on the virtual paper trading platform.